Gilead Sciences Inc. (NASDAQ:GILD) announced Monday that ithas filed a registration statement with the Securities andExchange Commission (SEC) for a secondary public offering ofthree million shares of common stock. The company hopes toraise between $44 and $50 million, depending on whether ornot over-allotment options are exercised in full.
The company raised $86.5 million in late January with thelargest initial public offering for a biotechnology companycompleted in 1992. All of the shares in the secondary offeringare being sold by the company. The offering will be managedby Robertson, Stephens and Co. and Hambrecht and Quist Inc.Gilead's stock closed Monday at $13.75, down 25 cents a share.
(c) 1997 American Health Consultants. All rights reserved.